Skip to main content

Streamline Your Mycoplasma Testing With BIOFIRE® Mycoplasma

In the high-stakes world of cell and gene therapy, timely and accurate mycoplasma testing is crucial. BIOFIRE® Mycoplasma delivers a transformative solution with its 1-hour in-house testing, designed to maximize efficiency and cut costs without compromising quality.

BIOFIRE® Mycoplasma Offers Cell & Gene Therapy Manufacturers the “Molecular Lab in a Pouch”:

BIOFIRE® Mycoplasma uses next-gen PCR technology to deliver in-house testing results in under an hour, saving you time and money on outsourced testing without adding significant workload. 

With just two minutes of hands-on time, its simple three-step workflow requires no expertise and no result interpretation. The closed “molecular lab in a pouch” enables data integrity, making rapid, reliable mycoplasma results possible.

   

Why BIOFIRE® Mycoplasma for Cell & Gene Therapies?

  • Fast Results
    Get reliable mycoplasma results in under one hour with BIOFIRE® Mycoplasma’s next-gen PCR technology, reducing dependence on costly outsourced testing.
  • Simple Workflow
    Perform accurate testing easily with a three-step process that requires only two minutes of hands-on time and no result interpretation.
  • Secure and Efficient
    Enjoy a “molecular lab in a pouch” with a closed-system design that enables data integrity and integrates seamlessly into your lab.
  • Cost Savings
    Cut costs and improve efficiency by bringing mycoplasma testing in-house, eliminating expenses for outsourced services and optimizing lab resources.

Interested in Saving Time and Money While Improving Your Testing Accuracy?

Complete the form below to get in touch with our team. A bioMérieux expert will be in touch using the contact information you provide. By providing your information, you agree to receive additional emails from bioMérieux about mycoplasma testing.

To find out more about the management of your personal data and to exercise your rights, see our privacy policy.

    

Discover how BIOFIRE® Mycoplasma “Molecular Lab in a Pouch” Automates Testing with a Shorter Time-To-Result

On-Demand Webinar

Regulatory Submission Strategy for Implementation and Validation of a New PCR-Based Technology for Mycoplasma Testing

Experts from Janssen, Pharmaceutical Companies of Johnson & Johnson, discuss their validation approach and strategy for PCR-based mycoplasma testing.

ACCESS WEBINAR

WHITE PAPER

Real-World Data From Cell Therapy Manufacturers

Two cell therapy manufacturers evaluated the BIOFIRE® FILMARRAY® 2.0 system for mycoplasma detection. Interested in the results? 

DOWNLOAD WHITE PAPER

PRODUCT PAGE

BIOFIRE® MYCOPLASMA

Did you know mycoplasma testing could be so easy? Discover the value of simplicity and take control of your process.

MORE DETAILS

Scientific Study Summary

BIOFIRE® Mycoplasma For Cell & Gene Therapy Samples

Two cell therapy and four bioproduction manufacturers evaluted the BIOFIRE® FILMARRAY® 2.0 — interested in the results in an easy-to-digest format? Download a one page Scientific Study Summary that details the study's objectives, outline, and conclusion!
DOWNLOAD
Close-up image of cell for Advanced Therapy and Cell & Gene Therapy CGT.

Cell & Gene Therapy Solutions

There’s no time to lose when a patient relies on your product. Streamlined quality control testing specific to cell and gene therapies yields safe, rapid and efficient results.

Discover Our Proven Portfolio Of Value-Added Solutions